OSX-200

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameOSX-200
Drug Alias NameOSX200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOssianix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOssianix Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A